New, non-invasive methods can help detect which epilepsy patients may be having seizures and allow clinicians to respond rapidly or to better plan surgeries for patients who are refractory to medical therapy.
Mark L. Fuerst
Nicotinamide may lower the incidence of new nonmelanoma skin cancers in patients at high risk for skin cancer, providing a new chemopreventive opportunity.
Surgery may offer relief from debilitating migraines. View the results of 3 different procedures.
To stent or not to stent? We present 3 studies with opposing responses to this question.
Several new studies feature developments in remyelination in MS. Oligodendrocyte precursor cells may be a promising target for MS treatments, and microRNA expression are perhaps an attractive MS biomarker.
Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.
This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.
A skin test used to detect elevated levels of abnormal proteins may allow earlier diagnosis of Alzheimer and Parkinson diseases, according to a new study.
A non-psychoactive component of the marijuana plant, cannabidiol in liquid form decreased seizures by an average of 50% across multiple types of severe epilepsy.
Highlights of recent findings about multiple sclerosis are summarized in this slide show.